Back to results
UnknownPhase 2

Safety, Tolerability and Effects of Mannitol in Parkinson's Disease

NCT03823638

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hadassah Medical Center

Jerusalem, Israel

Contact

David Arkadir, MD PhD

02-6777716arkadir@hadassah.org.il
View on ClinicalTrials.gov
Safety, Tolerability and Effects of Mannitol in Parkinson's Disease — TrialFind